多血管床病变在颈动脉内膜剥脱术和下肢旁路术患者中常见且与不良结局相关
基于血管质量倡议(VQI)2013-2019年数据,分析颈动脉内膜剥脱术(CEA,n=93,736)和腹股沟下下肢旁路术(LEB,n=25,223)患者。多血管床病变在CEA和LEB中均占47%,与围术期心肌梗死/死亡风险独立相关(CEA OR 1.59;LEB OR 1.78),5年生存率随受累血管床数目增加而降低。
要点
- CEA和LEB患者中多血管床病变患病率均为47%。
- 围术期心梗/死亡风险随受累血管床数目增加而升高。
- 多血管床病变独立关联5年死亡率升高(CEA HR 1.33;LEB HR 1.30)。
核心结论
- 多血管床病变在CEA和LEB患者中常见,与围术期心肌梗死/死亡风险升高及长期生存率降低相关。
- 血运重建后,多血管床病变患者应考虑更积极的心脏保护药物和更密切的随访。
研究设计与样本
- 回顾性队列研究,查询血管质量倡议(VQI)数据库2013-2019年CEA(n=93,736)或腹股沟下LEB(n=25,223)患者。
- 多血管床病变定义为颈动脉、冠状动脉和腹股沟下动脉床中超过一个存在动脉粥样硬化闭塞性疾病。
主要发现
- 多血管床病变在CEA中占47%(2个动脉床39.0%,3个动脉床7.6%;n=93,736),在LEB中占47%(2个动脉床41.0%,3个动脉床5.7%;n=25,223)。
- 围术期心肌梗死/死亡率随受累血管床数目增加而升高:CEA 1个床0.9% vs 2个床1.5% vs 3个床2.7%(P < .001);LEB 1个床2.2% vs 2个床5.3% vs 3个床6.6%(P < .001)。
- 多血管床病变独立关联围术期心肌梗死/死亡:CEA OR 1.59(95%CI 1.40-1.81;P < .0001);LEB OR 1.78(95%CI 1.52-2.08;P < .0001)。
- 5年生存率随受累血管床数目增加而降低:CEA 3个床82% vs 2个床88% vs 1个床92%(P < .01);LEB 3个床72% vs 2个床75% vs 1个床84%(P < .01)。
- 多血管床病变独立关联5年死亡率:CEA HR 1.33(95%CI 1.24-1.40;P = .0001);LEB HR 1.30(95%CI 1.20-1.41;P = .0001)。
临床怎么用
- 血运重建后,多血管床病变患者应考虑更积极的心脏保护药物和更密切的随访。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Polyvascular disease is strongly associated with increased risk of cardiovascular morbidity and mortality. However, its prevalence in patients undergoing carotid and lower extremity surgical revascularization and its impact on outcomes are unknown. METHODS: The Vascular Quality Initiative was queried for carotid endarterectomy (CEA) or infrainguinal lower extremity bypass (LEB), 2013-2019. Polyvascular disease was defined as presence of atherosclerotic occlusive disease in more than one arterial bed: carotid, coronary, and infrainguinal. Primary outcomes were (1) composite perioperative myocardial infarction (MI) or death and (2) 5-year survival. Patient characteristics and perioperative outcomes were evaluated using the χ2 test and multivariable logistic regression. Survival was analyzed using Kaplan-Meier method and Cox proportional hazards multivariable models. RESULTS: Polyvascular disease was identified in 47% of CEA (39.0% in 2 arterial beds, 7.6% in 3 arterial beds; n = 93,736) and 47% of LEB (41.0% in 2 arterial beds, 5.7% in 3 arterial beds; n = 25,223). For both CEA and LEB, patients with polyvascular disease had more comorbidities including hypertension, congestive heart disease, chronic obstructive pulmonary disease, smoking, diabetes mellitus, and end-stage renal disease (P < .0001). Perioperative MI/death rates increased with increasing number of vascular beds affected following CEA (0.9% in 1 bed vs 1.5% in 2 beds vs 2.7% in 3 beds; P < .001) and LEB (2.2% in 1 bed vs 5.3% in 2 beds vs 6.6% in 3 beds; P < .001). Polyvascular disease was associated independently with perioperative MI/death after CEA (odds ratio, 1.59; 95% confidence interval [CI], 1.40-1.81;P < .0001) and LEB (odds ratio, 1.78; 95% CI, 1.52-2.08; P < .0001). Five-year survival was decreased in patients with polyvascular disease after CEA (82% in 3 beds vs 88% in 2 beds vs 92% in 1 bed; P < .01) and LEB (72% in 3 beds vs 75% in 2 beds vs 84% in 1 bed; P < .01) in a dose-dependent manner, with the lowest 5-year survival observed in those with three arterial beds involved. Polyvascular disease was independently associated with 5-year mortality after CEA (hazard ratio, 1.33; 95% CI, 1.24-1.40; P = .0001) and LEB (hazard ratio, 1.30; 95% CI, 1.20-1.41; P = .0001). CONCLUSIONS: Polyvascular disease is common in patients undergoing CEA and LEB and is associated with a higher risk of perioperative MI/death and decreased long-term survival. After revascularization, patients with polyvascular disease should be considered for more aggressive cardioprotective medications and closer follow-up.
引用
- Boelitz KM, Forsyth A, Crawford A, et al. Polyvascular disease is common in patients undergoing carotid endarterectomy and lower extremity bypass and is associated with worse outcomes. J Vasc Surg. 2024. PMID: 38723911. doi:10.1016/j.jvs.2024.05.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。